Purchase Order HT942523P0135

Award Date 9/27/23
Potential Completion Date 9/26/28
Potential Value $169K
Ultimate Awardee
Qiagen N.V.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract award by the U.S. Army Corps of Engineers (USACE) to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $90,325.61 contract is for a 1-year software license for the Ingenuity Pathways Analysis (IPA) system, which supports biomedical research, public health, and healthcare programs. The contract was awarded on a sole-source basis without any set-aside designations. Qiagen provides a variety of molecular diagnostics...
This is a $573,796.56 firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Qiagen, LLC, a division of Qiagen N.V., for an "IPA W/ADVANCED ANALYTICS LCL SOFTWARE." The contract has an ultimate completion date of July 26, 2021 and was awarded on July 27, 2016. There is no set-aside designation mentioned. Qiagen is an international biotechnology company that provides sample and assay technologies for molecular diagnostics, applied testing, pharma, and...
This is a firm fixed-price purchase order contract awarded by the Northeast Area of a civilian federal agency to Qiagen, LLC, a division of Qiagen N.V. The contract is for the provision of IPA (Ingenuity Pathway Analysis), a functional genomic analysis software, which will be shared with five systems at the Beltsville Agricultural Research Center (BARC). The contract has a ceiling value of $31,733.00 and a completion date of February 28, 2025. Qiagen is a global provider of sample and assay...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC. The contract is for 4 annual licenses of Qiagen's IPA (Ingenuity Pathway Analysis) advanced analytics software, with a total ceiling value of $99,750.00. The contract does not have a set-aside designation. Qiagen is an international provider of sample and assay technologies, and has...
This is a firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Qiagen, LLC for annual software license and support subscription renewals of the QIAGEN Ingenuity Pathway Analysis (IPA) platform. The contract has a ceiling value of $170,495.00 and a performance period ending on December 31, 2021. No set-aside was used for this award. Qiagen, LLC is a...
This is a sole-source federal purchase order contract awarded by the United States Army Medical Research Acquisition Activity (USAMRAA) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, laboratory equipment, and bioinformatics software. The $131,518 firm-fixed-price contract is for the Qiagen Ingenuity Pathway Analysis (IPA) software, which is required by the U.S. Army Medical Research Institute for Infectious Diseases (USAMRIID) to analyze gene expression,...
This is a firm fixed-price purchase order awarded by the Shared Services Center, a civilian federal agency, to Qiagen, LLC, a division of the international provider Qiagen N.V. The contract has a ceiling value of $19,220.48 and a completion date of June 13, 2025. It is a renewal of a previous contract for "QIAGEN IPA ANALYSIS MATCH NUL" services, which likely refers to the provision of Qiagen's Ingenuity Pathway Analysis software and associated support. Qiagen is an experienced federal...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed-price purchase order to Qiagen, LLC, a division of the international provider Qiagen N.V., to provide IPA (Ingenuity Pathway Analysis) Analysis Match Explorer CL software licenses. The contract has a potential value of $139,495.00 and a performance period ending on August 31, 2023. This award does not utilize any set-aside designations. Qiagen has a history of...
This firm-fixed-price purchase order was awarded by the National Institute on Aging (NIA), a civilian agency, to Qiagen, LLC for a concurrent user license of Qiagen's Ingenuity Pathway Analysis (IPA) Match Explorer software. The total ceiling value of the contract is $47,277.00, with a period of performance through May 15, 2023. The contract was not set aside for any small business category. Qiagen, LLC is a division of the parent company Qiagen N.V., an international provider of sample and...
This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC for software licenses for NIDDK's IPA (Ingenuity Pathway Analysis) software. The contract has a ceiling value of $31,733.00 and a period of performance through September 28, 2025. Qiagen is a global provider of molecular diagnostics, applied testing, and bioinformatics...

This is a firm fixed price purchase order awarded by the Defense Health Agency (DHA) to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract, with a ceiling value of $168,598.05 and a period of performance through September 2028, provides Qiagen's Ingenuity Pathway Analysis (IPA) Match Explorer software for genomics, transcriptomics, epigenomics, and metabolomics analysis and interpretation to support various mission-critical projects at the Walter Reed Army Institute of Research (WRAIR). The contract also includes software support, maintenance, training, and technical support services. This purchase order is not associated with any set-aside designation.

Generated 10/7/24, 10:55 AM